Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Koen van der Sluijs"'
Autor:
Björn van der Ster, Marije Wijnberge, Marthe Huntelaar, Job de Haan, Koen van der Sluijs, Denise Veelo, Berend Westerhof
Publikováno v:
Artery Research, Vol 25, Iss 1 (2020)
Background: Hemodynamic optimization of unstable patients by means of fluid resuscitation improves patient outcome, but choosing the correct amount of fluid can be difficult. Too little fluid may not ensure adequate perfusion whereas too much fluid i
Externí odkaz:
https://doaj.org/article/79030fec174d4e898a4b9af096b94a71
Autor:
Christian Fastner, Heimo Mairbäurl, Nina C Weber, Koen van der Sluijs, Florian Hackl, Lorenz Hotz, Albert Dahan, Markus W Hollmann, Marc M Berger
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112622 (2014)
We previously demonstrated that intratracheally administered S-ketamine inhibits alveolar fluid clearance (AFC), whereas an intravenous (i.v.) bolus injection had no effect. The aim of the present study was to characterize whether continuous i.v. inf
Externí odkaz:
https://doaj.org/article/ef58b3630684447c9814e7482dfd0458
Autor:
Jos, Thannhauser, Joris, Nas, Koen, van der Sluijs, Hans, Zwart, Menko-Jan, de Boer, Niels, van Royen, Judith, Bonnes, Marc, Brouwer
Publikováno v:
Resuscitation, 174, 62-67. Elsevier Ireland Ltd
Resuscitation, 174, pp. 62-67
Resuscitation, 174, 62-67. Elsevier
Resuscitation, 174, 62-67
Resuscitation, 174, pp. 62-67
Resuscitation, 174, 62-67. Elsevier
Resuscitation, 174, 62-67
Introduction: On-scene detection of acute coronary occlusion (ACO) during ongoing ventricular fibrillation (VF) may facilitate patient-tailored triage and treatment during cardiac arrest. Experimental studies have demonstrated the diagnostic potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b667bc06573b9f890b0adc44ea15a23
https://doi.org/10.1016/j.resuscitation.2022.03.025
https://doi.org/10.1016/j.resuscitation.2022.03.025
Autor:
Marthe Huntelaar, Job de Haan, Björn J.P. van der Ster, Denise P. Veelo, Koen van der Sluijs, Marije Wijnberge, Berend E. Westerhof
Publikováno v:
Artery Research, Vol 25, Iss 1 (2020)
Background: Hemodynamic optimization of unstable patients by means of fluid resuscitation improves patient outcome, but choosing the correct amount of fluid can be difficult. Too little fluid may not ensure adequate perfusion whereas too much fluid i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf128317a18249be1981a0ec513f455
https://www.atlantis-press.com/article/125934577/view
https://www.atlantis-press.com/article/125934577/view
Autor:
René Lutter, Koen van der Sluijs, Peter J. Sterk, Barbara Smids, Marianne A. van de Pol, Peter I. Bonta, Koos Zwinderman, Tamara Dekker, Annemiek Dijkhuis, Yanaika S. Sabogal Piñeros, Lara Ravanetti, Suzanne M. Bal, Paul Brinkman, Christof J. Majoor
Publikováno v:
Airway cell biology and immunopathology.
Eosinophils are considered to drive the pathophysiology in asthma and therefore treatment is focused on reducing eosinophil numbers. Mepolizumab, a humanized monoclonal antibody that neutralizes interleukin 5 (IL-5), efficiently attenuates both syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31b519d5168516eb3a04530c841bb934
https://doi.org/10.1183/13993003.congress-2019.pa5200
https://doi.org/10.1183/13993003.congress-2019.pa5200
Autor:
René Lutter, Marianne A. van de Pol, Peter J. Sterk, Yanaika S. Sabogal Piñeros, Annemiek Dijkhuis, Koen van der Sluijs, Christof J. Majoor, Suzanne M. Bal, Lara Ravanetti, Peter I. Bonta, Paul Brinkman, Koos Zwinderman, Tamara Dekker, Barbara Smids
Publikováno v:
Airway Cell Biology and Immunopathology.
Eosinophils are considered to drive the pathophysiology in asthma and therefore treatment is focused on reducing eosinophil numbers. Mepolizumab, a humanized monoclonal antibody that neutralizes interleukin 5 (IL-5), efficiently attenuates both syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a2e4c33afa6b92ca8340cc53333aa65
https://doi.org/10.1183/23120541.lungscienceconference-2019.yi03
https://doi.org/10.1183/23120541.lungscienceconference-2019.yi03
Autor:
René Lutter, Lara Ravanetti, Peter J. Sterk, Yanaika S. Sabogal Piñeros, Tamara Dekker, Aeilko H. Zwinderman, Barbara Dierdorp, Peter I. Bonta, Christof J. Majoor, Koen van der Sluijs, Suzanne M. Bal, Paul Brinkman, Marianne A. van de Pol, Annemiek Dijkhuis
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 199(4), 508-517. American Thoracic Society
American journal of respiratory and critical care medicine, 199(4), 508-517. American Thoracic Society
American journal of respiratory and critical care medicine, 199(4), 508-517. American Thoracic Society
RATIONALE: Eosinophils drive pathophysiology in stable and exacerbating eosinophilic asthma, and therefore treatment is focused on the reduction of eosinophil numbers. Mepolizumab, a humanized monoclonal antibody that neutralizes IL-5 and efficiently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cacbe07e080ef672163393eaafa12ac
https://research.vumc.nl/en/publications/34d44881-8c04-4a04-a6ca-2052e88f0d71
https://research.vumc.nl/en/publications/34d44881-8c04-4a04-a6ca-2052e88f0d71
APRIL affects antibody responses and early leukocyte infiltration, but not influenza A viral control
Publikováno v:
Molecular immunology, 45(11), 3050-3058. Elsevier Limited
A proliferation inducing ligand (APRIL) is implicated in the regulation of class switch recombination to IgA in T-independent B cell responses. Since B cells play an important role in the immunity to influenza A virus and resistance against the virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47c48cf38a218f261d7128550dfb4af
https://doi.org/10.1016/j.molimm.2008.03.017
https://doi.org/10.1016/j.molimm.2008.03.017
Autor:
Allard C. van der Wal, Koen van der Sluijs, Peter Teeling, Mirza M. Idu, Guus F. Rimmelzwaan, Jelger J. van der Meer, M.M. Levi, Onno J. de Boer, Tymen T. Keller
Publikováno v:
Stroke; a journal of cerebral circulation, 39(1), 174-179. Lippincott Williams and Wilkins
Stroke, 39(1), 174-179. Lippincott Williams & Wilkins
Stroke, 39(1), 174-179. Lippincott Williams & Wilkins
Background and Purpose— Evidence is accumulating that infection with influenza A virus contributes to atherothrombotic disease. Vaccination against influenza decreases the risk of atherosclerotic syndromes, indicating that inflammatory mechanisms m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b021375acad414da4e7cce33317a3dec
https://pure.eur.nl/en/publications/b7233c8c-37b0-45df-83fe-242496156872
https://pure.eur.nl/en/publications/b7233c8c-37b0-45df-83fe-242496156872
Autor:
Sankar Ghosh, Joost H. N. Schuitemaker, Michael J. May, Esther C. de Jong, Najat Hajji, Paul P. Tak, Koen van der Sluijs, Martien L. Kapsenberg, Sander W. Tas, Margriet J. Vervoordeldonk
Publikováno v:
Blood, 110(5), 1540-1549. American Society of Hematology
Ligation of CD40 on dendritic cells (DCs) induces early production of inflammatory mediators via canonical NF-κB signaling, as well as late expression of the anti-inflammatory enzyme indoleamine 2,3-dioxygenase (IDO) via unknown signal transduction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfed78a06e5698db5acd4cae093249d7
https://doi.org/10.1182/blood-2006-11-056010
https://doi.org/10.1182/blood-2006-11-056010